0

Close
 
Upcoming Allied Market Research
2023
Animal Biotechnology Market

Animal Biotechnology Market: Global Opportunity Analysis and Industry Forecast, 2023-2030 Market

LS : Diagnostics and Biotech
Report Code: A10379
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Animal Biotechnology Market

Request Now !

Animal biotechnology is the branch of biotechnology, which deals with the molecular biology techniques for developing genetically engineered animals which is appropriate for pharmaceutical, industrial or agricultural applications. Biotechnology was introduced in animal healthcare in 19th century. When the first vaccines were prepared for its use in animals. Biotechnology applications help in detecting and treating both infectious and parasitic diseases of animals. To reduce the risk and prevent the outbreak of infectious diseases, the World Organization for Animal Health (OIE) help to detect the infectious disease and provide particular treatment for the animal. 

Animal-Biotechnology

For preventing the disease several reagents, diagnostic techniques and vaccine have been manufacture, which are more specific, sensitive, rapid, reproducible that have been updated through recent discoveries in biochemistry, immunology and molecular biology such as monoclonal antibodies, nucleic probes, DNA amplification and others. Vaccination is an effective way to reduce disease burden in animals and plays an important role in preventive health and disease control. The development of new vaccines include subunit vaccines, anti-idiotype vaccines, synthetic vaccines, recombinant vaccines, which is effective, duration of protection, ease of use, stability and multivalence. Thus, the important aim of animal health biotechnology is to serve human healthcare as well as its environment at the same time.

COVID-19 Scenario Analysis:

The coronavirus pandemic is having a huge impact on businesses and has already caused an unprecedented collapse of economic activities. The COVID-19 impact is straining the healthcare systems globally. The rapidly increasing demand for healthcare facilities and healthcare workers may leave only a few healthcare systems to fulfill the increasing demand during the pandemic situation. 

The COVID-19 pandemic cases are because of direct or indirect contact between humans. There has been no evidence or confirmation that animals can spread COVID-19 to humans. The myth animals can spread the virus to humans has increased the number of abandoned pets. Furthermore, COVID-19 has weakened the supply chain and has created shortage of animal health products such as nutritional feed as well as vaccines globally. The animal health industry has been impacted largely as many manufacturers in animal health industry are left with a significantly reduced workforce. Also, stringent government policies such as restrictions of import of raw materials from China is expected to hamper the animal health market. 

Ongoing spread of covid-19, positively impacted on animal biotechnology market.  For the first time, one of the many COVID-19 vaccines in development has protected an animal, rhesus macaques, from infection by the new coronavirus. The vaccine, an old-fashioned formulation consisting of a chemically inactivated version of the virus, produced no obvious side effects in the monkeys, and human trials. Recently in April 2020 “Sinovac Biotech”, researcher gave two different doses of their COVID-19 vaccine to a total of eight rhesus macaques. 

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

Globally North America and Europe dominate the overall animal biotechnology market due to the increasing incidence of various animal diseases, rising awareness levels of the population about cloning and transgenic rising animal meat consumption, large investment in research and development activities from both public and private firms the rising animal healthcare expenditure, and others. Whereas, Asia-Pacific region is expected to drive the market growth due to dependency of various regions on animals for their daily activities, increasing demand for animal and availability of huge livestock population.

As per the “Statistics of Scientific Procedures on Living Animals Great Britain” in 2017, reported that in 2017, 3.79 million animal diagnosis procedures were carried out. According to US Food and Drug Administration (FDA), in 2019, scientists have successfully cloned many livestock species, including cattle, swine, sheep, and goats. Globally, animal cloning has gained popularity and acceptance, as a method to produce genetically identical animals. Also state that United Kingdom involving living animals, out of which, total 1.89 million were approved out for experimental purposes, and 1.90 million were counted under the breeding of genetically altered animals. According to Veterinary Cancer Society estimates, every year more than 6 million cats and dogs are diagnosed with cancer in the United States.

Major factors such as increasing production of vaccines, advancements in cloning and development of transgenic animals will add to the animal’s ability to fight diseases, favorable government policies and supportive approval agencies, growing research and development activities, the rising regulatory approvals, rising demand for animals will further help in the growth of this market in future, are drive the growth of animal biotechnology market.  

New product launches to flourish the market:

Manufacturers have been focusing on producing new products for specific applications as there are varying demands based on the utilization. Leading market players have determined how improved accuracy can be influential in many applications. It is a promising compound for the therapy and prophylaxis of all forms of theileriosis. In 2018, “Arka Pharmaceutical” has launched new veterinary vaccines such as “Buparvaquone Injection” has been shown to have anti-leishmanial activity in vitro. It can be used to treat in vitro bovine east coast fever protozoa. In 2019, “Sayavet” has launched new medicinal drug product such as “Carprofen Caplets” is a non-steroidal anti-inflammatory drug (NSAID) that is used to reduce pain and inflammation (soreness) due to osteoarthritis and pain following surgery in dogs. Carprofen Caplets is a prescription drug for dogs. It is available as a caplet and is given to dogs by mouth.

Key benefits of the report:

  • This study presents the analytical depiction of the global animal biotechnology market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the animal biotechnology market share.
  • The current market is quantitatively analyzed to highlight the global animal biotechnology market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed global animal biotechnology market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the Animal Biotechnology Market research report:

  • Who are the leading market players active in the animal biotechnology market?
  • What are the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that will help in taking further strategic steps?

 Animal Biotechnology Market: Global Opportunity Analysis and Industry Forecast, 2020–2027 Report Highlights

Aspects Details
By Product
  • Vaccine
  • Drug
  • Diagnostic Test
  • Reproductive And Genetic Product
By Application
  • Food Safety And Drug Development
  • Development Of Animal Pharmaceutical
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Merck and Co. Inc, Zoetis Inc, Santa Cruz Biotechnology, Inc., Boehringer Ingelheim GmbH, Pfizer Inc, Biogenesis Bago, Virbac, Ivaoes, LLC, Bayer AG, Sanofi
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: ANIMAL BIOTECHNOLOGY MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Vaccine

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Drug

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Diagnostic Test

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Reproductive And Genetic Product

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Food Safety And Drug Development

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Development Of Animal Pharmaceutical

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Others

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: ANIMAL BIOTECHNOLOGY MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product

      • 6.2.3. Market Size and Forecast, By Application

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Animal Biotechnology Market

        • 6.2.5.1. Market Size and Forecast, By Product
        • 6.2.5.2. Market Size and Forecast, By Application

      • 6.2.6. Canada Animal Biotechnology Market

        • 6.2.6.1. Market Size and Forecast, By Product
        • 6.2.6.2. Market Size and Forecast, By Application

      • 6.2.7. Mexico Animal Biotechnology Market

        • 6.2.7.1. Market Size and Forecast, By Product
        • 6.2.7.2. Market Size and Forecast, By Application

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product

      • 6.3.3. Market Size and Forecast, By Application

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Animal Biotechnology Market

        • 6.3.5.1. Market Size and Forecast, By Product
        • 6.3.5.2. Market Size and Forecast, By Application

      • 6.3.6. Germany Animal Biotechnology Market

        • 6.3.6.1. Market Size and Forecast, By Product
        • 6.3.6.2. Market Size and Forecast, By Application

      • 6.3.7. Italy Animal Biotechnology Market

        • 6.3.7.1. Market Size and Forecast, By Product
        • 6.3.7.2. Market Size and Forecast, By Application

      • 6.3.8. Spain Animal Biotechnology Market

        • 6.3.8.1. Market Size and Forecast, By Product
        • 6.3.8.2. Market Size and Forecast, By Application

      • 6.3.9. UK Animal Biotechnology Market

        • 6.3.9.1. Market Size and Forecast, By Product
        • 6.3.9.2. Market Size and Forecast, By Application

      • 6.3.10. Russia Animal Biotechnology Market

        • 6.3.10.1. Market Size and Forecast, By Product
        • 6.3.10.2. Market Size and Forecast, By Application

      • 6.3.11. Rest Of Europe Animal Biotechnology Market

        • 6.3.11.1. Market Size and Forecast, By Product
        • 6.3.11.2. Market Size and Forecast, By Application

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product

      • 6.4.3. Market Size and Forecast, By Application

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Animal Biotechnology Market

        • 6.4.5.1. Market Size and Forecast, By Product
        • 6.4.5.2. Market Size and Forecast, By Application

      • 6.4.6. Japan Animal Biotechnology Market

        • 6.4.6.1. Market Size and Forecast, By Product
        • 6.4.6.2. Market Size and Forecast, By Application

      • 6.4.7. India Animal Biotechnology Market

        • 6.4.7.1. Market Size and Forecast, By Product
        • 6.4.7.2. Market Size and Forecast, By Application

      • 6.4.8. South Korea Animal Biotechnology Market

        • 6.4.8.1. Market Size and Forecast, By Product
        • 6.4.8.2. Market Size and Forecast, By Application

      • 6.4.9. Australia Animal Biotechnology Market

        • 6.4.9.1. Market Size and Forecast, By Product
        • 6.4.9.2. Market Size and Forecast, By Application

      • 6.4.10. Thailand Animal Biotechnology Market

        • 6.4.10.1. Market Size and Forecast, By Product
        • 6.4.10.2. Market Size and Forecast, By Application

      • 6.4.11. Malaysia Animal Biotechnology Market

        • 6.4.11.1. Market Size and Forecast, By Product
        • 6.4.11.2. Market Size and Forecast, By Application

      • 6.4.12. Indonesia Animal Biotechnology Market

        • 6.4.12.1. Market Size and Forecast, By Product
        • 6.4.12.2. Market Size and Forecast, By Application

      • 6.4.13. Rest of Asia Pacific Animal Biotechnology Market

        • 6.4.13.1. Market Size and Forecast, By Product
        • 6.4.13.2. Market Size and Forecast, By Application

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product

      • 6.5.3. Market Size and Forecast, By Application

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Animal Biotechnology Market

        • 6.5.5.1. Market Size and Forecast, By Product
        • 6.5.5.2. Market Size and Forecast, By Application

      • 6.5.6. South Africa Animal Biotechnology Market

        • 6.5.6.1. Market Size and Forecast, By Product
        • 6.5.6.2. Market Size and Forecast, By Application

      • 6.5.7. Saudi Arabia Animal Biotechnology Market

        • 6.5.7.1. Market Size and Forecast, By Product
        • 6.5.7.2. Market Size and Forecast, By Application

      • 6.5.8. UAE Animal Biotechnology Market

        • 6.5.8.1. Market Size and Forecast, By Product
        • 6.5.8.2. Market Size and Forecast, By Application

      • 6.5.9. Argentina Animal Biotechnology Market

        • 6.5.9.1. Market Size and Forecast, By Product
        • 6.5.9.2. Market Size and Forecast, By Application

      • 6.5.10. Rest of LAMEA Animal Biotechnology Market

        • 6.5.10.1. Market Size and Forecast, By Product
        • 6.5.10.2. Market Size and Forecast, By Application

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Bayer AG

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Biogenesis Bago

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Boehringer Ingelheim GmbH

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Ivaoes, LLC

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Merck And Co. Inc

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Pfizer Inc

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Sanofi

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Santa Cruz Biotechnology, Inc.

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Virbac

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Zoetis Inc

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL BIOTECHNOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL ANIMAL BIOTECHNOLOGY MARKET FOR VACCINE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL ANIMAL BIOTECHNOLOGY MARKET FOR DRUG, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL ANIMAL BIOTECHNOLOGY MARKET FOR DIAGNOSTIC TEST, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL ANIMAL BIOTECHNOLOGY MARKET FOR REPRODUCTIVE AND GENETIC PRODUCT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL ANIMAL BIOTECHNOLOGY MARKET FOR FOOD SAFETY AND DRUG DEVELOPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL ANIMAL BIOTECHNOLOGY MARKET FOR DEVELOPMENT OF ANIMAL PHARMACEUTICAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL ANIMAL BIOTECHNOLOGY MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL ANIMAL BIOTECHNOLOGY MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA ANIMAL BIOTECHNOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. NORTH AMERICA ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 14. U.S. ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 15. U.S. ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 16. CANADA ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 17. CANADA ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 18. MEXICO ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 19. MEXICO ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 20. EUROPE ANIMAL BIOTECHNOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. EUROPE ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 22. EUROPE ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 23. FRANCE ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 24. FRANCE ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. GERMANY ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 26. GERMANY ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. ITALY ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 28. ITALY ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. SPAIN ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 30. SPAIN ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 31. UK ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 32. UK ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. RUSSIA ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 34. RUSSIA ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. REST OF EUROPE ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 36. REST OF EUROPE ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 37. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 38. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 39. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 40. CHINA ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 41. CHINA ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. JAPAN ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 43. JAPAN ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 44. INDIA ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 45. INDIA ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. SOUTH KOREA ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 47. SOUTH KOREA ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. AUSTRALIA ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 49. AUSTRALIA ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. THAILAND ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 51. THAILAND ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 52. MALAYSIA ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 53. MALAYSIA ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. INDONESIA ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 55. INDONESIA ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 57. REST OF ASIA PACIFIC ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. LAMEA ANIMAL BIOTECHNOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 59. LAMEA ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. LAMEA ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. BRAZIL ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 62. BRAZIL ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 63. SOUTH AFRICA ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH AFRICA ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 65. SAUDI ARABIA ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 66. SAUDI ARABIA ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. UAE ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 68. UAE ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 69. ARGENTINA ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 70. ARGENTINA ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 71. REST OF LAMEA ANIMAL BIOTECHNOLOGY, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 72. REST OF LAMEA ANIMAL BIOTECHNOLOGY, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 73. BAYER AG: KEY EXECUTIVES
  • TABLE 74. BAYER AG: COMPANY SNAPSHOT
  • TABLE 75. BAYER AG: OPERATING SEGMENTS
  • TABLE 76. BAYER AG: PRODUCT PORTFOLIO
  • TABLE 77. BAYER AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 78. BIOGENESIS BAGO: KEY EXECUTIVES
  • TABLE 79. BIOGENESIS BAGO: COMPANY SNAPSHOT
  • TABLE 80. BIOGENESIS BAGO: OPERATING SEGMENTS
  • TABLE 81. BIOGENESIS BAGO: PRODUCT PORTFOLIO
  • TABLE 82. BIOGENESIS BAGO: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. BOEHRINGER INGELHEIM GMBH: KEY EXECUTIVES
  • TABLE 84. BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT
  • TABLE 85. BOEHRINGER INGELHEIM GMBH: OPERATING SEGMENTS
  • TABLE 86. BOEHRINGER INGELHEIM GMBH: PRODUCT PORTFOLIO
  • TABLE 87. BOEHRINGER INGELHEIM GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 88. IVAOES, LLC: KEY EXECUTIVES
  • TABLE 89. IVAOES, LLC: COMPANY SNAPSHOT
  • TABLE 90. IVAOES, LLC: OPERATING SEGMENTS
  • TABLE 91. IVAOES, LLC: PRODUCT PORTFOLIO
  • TABLE 92. IVAOES, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 93. MERCK AND CO. INC: KEY EXECUTIVES
  • TABLE 94. MERCK AND CO. INC: COMPANY SNAPSHOT
  • TABLE 95. MERCK AND CO. INC: OPERATING SEGMENTS
  • TABLE 96. MERCK AND CO. INC: PRODUCT PORTFOLIO
  • TABLE 97. MERCK AND CO. INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 98. PFIZER INC: KEY EXECUTIVES
  • TABLE 99. PFIZER INC: COMPANY SNAPSHOT
  • TABLE 100. PFIZER INC: OPERATING SEGMENTS
  • TABLE 101. PFIZER INC: PRODUCT PORTFOLIO
  • TABLE 102. PFIZER INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103. SANOFI: KEY EXECUTIVES
  • TABLE 104. SANOFI: COMPANY SNAPSHOT
  • TABLE 105. SANOFI: OPERATING SEGMENTS
  • TABLE 106. SANOFI: PRODUCT PORTFOLIO
  • TABLE 107. SANOFI: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. SANTA CRUZ BIOTECHNOLOGY, INC.: KEY EXECUTIVES
  • TABLE 109. SANTA CRUZ BIOTECHNOLOGY, INC.: COMPANY SNAPSHOT
  • TABLE 110. SANTA CRUZ BIOTECHNOLOGY, INC.: OPERATING SEGMENTS
  • TABLE 111. SANTA CRUZ BIOTECHNOLOGY, INC.: PRODUCT PORTFOLIO
  • TABLE 112. SANTA CRUZ BIOTECHNOLOGY, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. VIRBAC: KEY EXECUTIVES
  • TABLE 114. VIRBAC: COMPANY SNAPSHOT
  • TABLE 115. VIRBAC: OPERATING SEGMENTS
  • TABLE 116. VIRBAC: PRODUCT PORTFOLIO
  • TABLE 117. VIRBAC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. ZOETIS INC: KEY EXECUTIVES
  • TABLE 119. ZOETIS INC: COMPANY SNAPSHOT
  • TABLE 120. ZOETIS INC: OPERATING SEGMENTS
  • TABLE 121. ZOETIS INC: PRODUCT PORTFOLIO
  • TABLE 122. ZOETIS INC: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SEGMENTATION
  • FIGURE 2. GLOBAL ANIMAL BIOTECHNOLOGY MARKET
  • FIGURE 3. SEGMENTATION ANIMAL BIOTECHNOLOGY MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN ANIMAL BIOTECHNOLOGY MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALANIMAL BIOTECHNOLOGY MARKET
  • FIGURE 11. ANIMAL BIOTECHNOLOGY MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. ANIMAL BIOTECHNOLOGY MARKET FOR VACCINE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. ANIMAL BIOTECHNOLOGY MARKET FOR DRUG, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. ANIMAL BIOTECHNOLOGY MARKET FOR DIAGNOSTIC TEST, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. ANIMAL BIOTECHNOLOGY MARKET FOR REPRODUCTIVE AND GENETIC PRODUCT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. ANIMAL BIOTECHNOLOGY MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 17. ANIMAL BIOTECHNOLOGY MARKET FOR FOOD SAFETY AND DRUG DEVELOPMENT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. ANIMAL BIOTECHNOLOGY MARKET FOR DEVELOPMENT OF ANIMAL PHARMACEUTICAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. ANIMAL BIOTECHNOLOGY MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 24. COMPETITIVE DASHBOARD
  • FIGURE 25. COMPETITIVE HEATMAP: ANIMAL BIOTECHNOLOGY MARKET
  • FIGURE 26. Top player positioning, 2022
  • FIGURE 27. BAYER AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 28. BAYER AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 29. BAYER AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 30. BIOGENESIS BAGO: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 31. BIOGENESIS BAGO: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 32. BIOGENESIS BAGO: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 33. BOEHRINGER INGELHEIM GMBH: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. BOEHRINGER INGELHEIM GMBH: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. BOEHRINGER INGELHEIM GMBH: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. IVAOES, LLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. IVAOES, LLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. IVAOES, LLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. MERCK AND CO. INC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. MERCK AND CO. INC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. MERCK AND CO. INC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. PFIZER INC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. PFIZER INC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. PFIZER INC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. SANOFI: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. SANOFI: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. SANOFI: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. SANTA CRUZ BIOTECHNOLOGY, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. SANTA CRUZ BIOTECHNOLOGY, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. SANTA CRUZ BIOTECHNOLOGY, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. VIRBAC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. VIRBAC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. VIRBAC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. ZOETIS INC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. ZOETIS INC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. ZOETIS INC: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Animal Biotechnology Market

Start reading.
This Report and over 67,068+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers